Cargando…
Risk factors for Clostridium difficile infection in hemato-oncological patients: A case control study in 144 patients
Evidence on risk factors for Clostridium difficile infection (CDI) in hemato-oncologic patients is conflicting. We studied risk factors for CDI in a large, well-characterized cohort of hemato-oncological patients. 144 hemato-oncological patients were identified in this retrospective, single center s...
Autores principales: | Fuereder, Thorsten, Koni, Danjel, Gleiss, Andreas, Kundi, Michael, Makristathis, Athanasios, Zielinski, Christoph, Steininger, Christoph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4980611/ https://www.ncbi.nlm.nih.gov/pubmed/27510591 http://dx.doi.org/10.1038/srep31498 |
Ejemplares similares
-
Comprehensive evaluation of chemiluminescent immunoassays for the laboratory diagnosis of Clostridium difficile infection
por: Makristathis, A., et al.
Publicado: (2017) -
High Prevalence of Genetically Related Clostridium Difficile Strains at a Single Hemato-Oncology Ward Over 10 Years
por: Waker, Edyta, et al.
Publicado: (2020) -
Serum parameters as prognostic biomarkers in a real world cancer patient population treated with anti PD-1/PD-L1 therapy
por: Minichsdorfer, Christoph, et al.
Publicado: (2022) -
Cessation of Ciprofloxacin Prophylaxis in Hemato-Oncology Patients
por: Caldwell, Louise, et al.
Publicado: (2022) -
Stem Cells in Hemato-Oncology
por: Damodar, S
Publicado: (2006)